Fibromyalgia in cancer patients: a systematic review and clinical implications for integrated care - Top-Institutions - MDSpire

Fibromyalgia in cancer patients: a systematic review and clinical implications for integrated care

  • By

  • Melania Prete

  • Giuseppe Porciello

  • Elvira Palumbo

  • Sara Vitale

  • Maurizio Marchesini

  • Sabrina Bimonte

  • Francesco Del Prato

  • Arturo Cuomo

  • Marco Cascella

  • Maria Grimaldi

  • Natalia Russo

  • Assunta Luongo

  • Anna Crispo

  • June 11, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of Michigan
    University of Michigan

    Ann Arbor, Michigan

    Key Differentiators

    • Pain Medicine
    • Oncology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Pain Medicine
    • Oncology

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Integrative Medicine

  • #4

    University of California, San Francisco
    University of California, San Francisco

    San Francisco, California

    Key Differentiators

    • Pain Medicine
    • Oncology

  • #5

    University of Texas MD Anderson Cancer Center
    University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Integrative Medicine

Original Source(s)

Fibromyalgia in cancer patients: a systematic review and clinical implications for integrated care

  • by Melania Prete, Giuseppe Porciello, Elvira Palumbo, Sara Vitale, Maurizio Marchesini, Sabrina Bimonte, Francesco Del Prato, Arturo Cuomo, Marco Cascella, Maria Grimaldi, Natalia Russo, Assunta Luongo, Anna Crispo

  • June 11, 2026

Related Content

Precision Diagnostics and the ADC Revolution

Antibody-drug conjugates are transforming cancer care, but their success depends on more precise, sensitive, and data-driven diagnostics

  • June 10, 2026

  • 15 min
Association between HLA-DRB1*04:05 and the efficacy of immune checkpoint inhibitors for patients with advanced cancer

Spatial immune archetypes in gastric and colorectal cancer: a proposed conceptual framework for immunotherapy resistance and therapeutic remodeling